Cleared Traditional

K002262 - DIAMEDIX IS-HSV 1&2 IGM TEST SYSTEM

K002262 is an FDA 510(k) clearance for DIAMEDIX IS-HSV 1&2 IGM TEST SYSTEM, manufactured by Diamedix Corp.. The device is a Class 2 Microbiology device with product code LGC cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K002262 · Diamedix Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2000
Decision
126d
Days
Class 2
Risk

K002262 is an FDA 510(k) clearance for the DIAMEDIX IS-HSV 1&2 IGM TEST SYSTEM. Classified as Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific (product code LGC), Class II - Special Controls.

Submitted by Diamedix Corp. (Miami, US). The FDA issued a Cleared decision on November 28, 2000 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3305 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Diamedix Corp. devices

FDA 510(k) Submission Details - K002262

510(k) Number K002262 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2000
Decision Date November 28, 2000
Days to Decision 126 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 102d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LGC Device Classification - Class 2, Special Controls

Product Code LGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3305
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LGC Enzyme Linked Immunoabsorbent Assay, Herpes Simplex Virus, Non-specific

All 32
Devices cleared under the same product code (LGC) and FDA review panel - the closest regulatory comparables to K002262.
MODIFICATION TO IMMULITE HERPES I & II IGG, MODEL L2KHS2 & L2KHS6
K010878 · Diagnostic Products Corp. · Apr 2001
THE APTUS (AUTOMATED) APPLICATION OF THE HSV 1/2 IGM ELISA TEST SYSTEM. AN ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) FOR
K992166 · Zeus Scientific, Inc. · Sep 1999
POCKIT HSV 2 RAPID TEST
K983886 · Diagnology , Ltd. · Aug 1999
PREMIER TYPE SPECIFIC HSV-2 IGG ELISA TEST
K984346 · Meridian Diagnostics, Inc. · Jun 1999
HSV-1 AND/OR -2 IGM ELISA TEST SYSTEM
K983656 · Zeus Scientific, Inc. · Mar 1999
HSV 1+2 IGG ELISA TEST
K983541 · Gull Laboratories, Inc. · Feb 1999